Dover Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.3M Sell
13,496
-2,286
-14% -$532K 1.36% 17
2025
Q4
$3.27M Sell
15,782
-270
-2% -$53.4K 1.27% 18
2025
Q3
$2.98M Sell
16,052
-179
-1% -$30.7K 1.19% 19
2025
Q2
$2.48M Sell
16,231
-2,077
-11% -$319K 1.09% 22
2025
Q1
$3.04M Buy
18,308
+5,028
+38% +$787K 1.32% 17
2024
Q4
$1.92M Sell
13,280
-74
-0.6% -$11.5K 1.1% 27
2024
Q3
$2.16M Sell
13,354
-1,834
-12% -$292K 1.23% 23
2024
Q2
$2.22M Buy
15,188
+652
+4% +$97K 1.37% 18
2024
Q1
$2.3M Buy
14,536
+6,110
+73% +$973K 1.58% 17
2023
Q4
$1.32M Sell
8,426
-3,777
-31% -$579K 1.74% 16
2023
Q3
$1.9M Buy
12,203
+50
+0.4% +$8.25K 1.92% 12
2023
Q2
$2.01M Sell
12,153
-666
-5% -$107K 1.78% 15
2023
Q1
$1.99M Buy
12,819
+834
+7% +$135K 1.91% 10
2022
Q4
$2.12M Buy
+11,985
New +$2.07M 2.28% 8

Other funds holding JNJ

Dover Advisors's JNJ Position: Q1 2026 in Review

Dover Advisors reduced its Johnson & Johnson (JNJ) stake by 14% in Q1 2026, selling an estimated $532K and leaving 13,496 shares worth $3.3M. The position accounts for 1.36% of the portfolio, ranked #17.

Dover Advisors first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Dover Advisors held 13,496 shares of Johnson & Johnson worth $3.3M as of Q1 2026.
  • Dover Advisors sold 2,286 Johnson & Johnson shares in Q1 2026, an estimated $532K.
  • Johnson & Johnson made up 1.36% of Dover Advisors's portfolio in Q1 2026, its #17 holding.
  • Dover Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Dover Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.